Home Cart 0 Sign in  

[ CAS No. 18063-03-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 18063-03-1
Chemical Structure| 18063-03-1
Structure of 18063-03-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 18063-03-1 ]

Related Doc. of [ 18063-03-1 ]

Alternatived Products of [ 18063-03-1 ]

Product Details of [ 18063-03-1 ]

CAS No. :18063-03-1 MDL No. :MFCD00007972
Formula : C7H5F2NO Boiling Point : -
Linear Structure Formula :- InChI Key :AVRQBXVUUXHRMY-UHFFFAOYSA-N
M.W : 157.12 Pubchem ID :87439
Synonyms :

Calculated chemistry of [ 18063-03-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 34.45
TPSA : 43.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.15
Log Po/w (XLOGP3) : 0.25
Log Po/w (WLOGP) : 1.9
Log Po/w (MLOGP) : 2.06
Log Po/w (SILICOS-IT) : 1.82
Consensus Log Po/w : 1.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.31
Solubility : 7.71 mg/ml ; 0.0491 mol/l
Class : Very soluble
Log S (Ali) : -0.72
Solubility : 30.2 mg/ml ; 0.193 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.53
Solubility : 0.462 mg/ml ; 0.00294 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 18063-03-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 18063-03-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 18063-03-1 ]
  • Downstream synthetic route of [ 18063-03-1 ]

[ 18063-03-1 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 18063-02-0 ]
  • [ 18063-03-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
[3] Molecules, 2010, vol. 15, # 6, p. 4267 - 4282
[4] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 5, p. 3037 - 3042
[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2544 - 2546
[6] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 14, p. 3263 - 3270
[7] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 16, p. 4127 - 4132
  • 2
  • [ 75-52-5 ]
  • [ 1897-52-5 ]
  • [ 18063-03-1 ]
YieldReaction ConditionsOperation in experiment
80% With copper(l) iodide; caesium carbonate; 1,8-diazabicyclo[5.4.0]undec-7-ene In water at 20 - 100℃; for 1 h; To a nitromethane (0.1 mL) solution of 2,6-difluorobenzonitrile (1j) (30 mg, 0.216 mmol) were addedH2O (1.0 mL), DBU (66 mg, 0.431 mmol), copper (I) iodide (8.2 mg, 0.0431 mmol), cesium (I)carbonate (35 mg, 0.108 mmol) at room temperature. The reaction mixture was heated at 100 °C for1 h and then poured into water (50 mL). The organic layer was separated and the aqueous layer wasextracted with AcOEt. The combined organic layer was dried over MgSO4. The solvent wasremoved under reduced pressure. The residue was purified by preparative TLC on silica gel elutingwith AcOEt-n-hexane (1:1) to give 2,6-difluorobenzamide (2j)S8 (27 mg, 80percent) as pale yellow powdersand (Z)-1-(2,6-difluorophenyl)-2-nitroethen-1-amine (3j)S2 (1 mg, 2percent) as pale yellow powders.mp 138-140 °C,
Reference: [1] Synlett, 2018, vol. 29, # 15, p. 2061 - 2065
  • 3
  • [ 1897-52-5 ]
  • [ 18063-03-1 ]
YieldReaction ConditionsOperation in experiment
80.6% With sulfuric acid In ice-water; water (1c)
2,6-Difluorobenzamide
To 240 g of concentrated sulfuric acid and 24 ml of water are added dropwise, at room temperature, 100 g (0.72 mol) of 2,6-difluorobenzonitrile.
The reaction mixture is stirred at 80°-85° C. for 12 hours, and then poured into 1.2 kg of ice-water; the mixture is stirred for 30 minutes and subsequently filtered.
The crystals are washed neutral with water, and are afterwards dried at 85° C. in vacuo; yield: 91.0 g (80.6percent), melting point: 140°-141.5° C.
Reference: [1] Tetrahedron, 1989, vol. 45, # 5, p. 1347 - 1354
[2] Polish Journal of Chemistry, 1991, vol. 65, # 5-6, p. 1049 - 1053
[3] Tetrahedron Letters, 1995, vol. 36, # 47, p. 8657 - 8660
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2003, vol. 42, # 11, p. 2814 - 2819
[5] Patent: US4560770, 1985, A,
[6] Journal of Medicinal Chemistry, 2009, vol. 52, # 17, p. 5295 - 5298
[7] Tetrahedron Letters, 2010, vol. 51, # 13, p. 1639 - 1641
  • 4
  • [ 385-00-2 ]
  • [ 18063-03-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 1, p. 162 - 166
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
[3] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
[4] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 5, p. 3037 - 3042
[5] Letters in Drug Design and Discovery, 2016, vol. 13, # 4, p. 329 - 334
[6] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2544 - 2546
[7] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 14, p. 3263 - 3270
[8] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 16, p. 4127 - 4132
[9] European Journal of Medicinal Chemistry, 2018, vol. 149, p. 170 - 181
  • 5
  • [ 1897-52-5 ]
  • [ 18063-03-1 ]
  • [ 385-00-2 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 52, p. 9561 - 9564
[2] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 8, p. 1099 - 1104
[3] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 8, p. 1099 - 1104
  • 6
  • [ 19064-16-5 ]
  • [ 18063-03-1 ]
Reference: [1] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
  • 7
  • [ 104-12-1 ]
  • [ 79-34-5 ]
  • [ 18063-03-1 ]
  • [ 35367-38-5 ]
Reference: [1] Patent: US4117009, 1978, A,
  • 8
  • [ 372-18-9 ]
  • [ 18063-03-1 ]
Reference: [1] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
[2] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
  • 9
  • [ 216064-18-5 ]
  • [ 18063-03-1 ]
Reference: [1] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
  • 10
  • [ 135133-56-1 ]
  • [ 18063-03-1 ]
Reference: [1] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
  • 11
  • [ 18063-03-1 ]
  • [ 53981-23-0 ]
Reference: [1] Patent: US5410082, 1995, A,
Same Skeleton Products
Historical Records